999 related articles for article (PubMed ID: 18824371)
21. The utility of estrogen receptor, progesterone receptor, and Her-2/neu status to predict survival in patients undergoing hepatic resection for breast cancer metastases.
Martinez SR; Young SE; Giuliano AE; Bilchik AJ
Am J Surg; 2006 Feb; 191(2):281-3. PubMed ID: 16442961
[TBL] [Abstract][Full Text] [Related]
22. Vascular endothelial growth factor expression in metastatic pulmonary tumor from colorectal carcinoma: utility as a prognostic factor.
Tamura M; Oda M; Tsunezuka Y; Matsumoto I; Kawakami K; Watanabe G
J Thorac Cardiovasc Surg; 2004 Oct; 128(4):517-22. PubMed ID: 15457151
[TBL] [Abstract][Full Text] [Related]
23. [Surgical treatment of pulmonary metastases of colorectal cancers. 8-year survival and main prognostic factors].
Baron O; Hamy A; Roussel JC; Galetta D; al Habash O; Duveau D; Despins P; de Lajartre AY; Michaud JL
Rev Mal Respir; 1999 Nov; 16(5):809-15. PubMed ID: 10612150
[TBL] [Abstract][Full Text] [Related]
24. Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan.
Sharif MA; Mamoon N; Mushtaq S; Khadim MT
J Coll Physicians Surg Pak; 2009 Feb; 19(2):99-103. PubMed ID: 19208313
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary resection for metastases of colorectal adenocarcinoma.
Riquet M; Foucault C; Cazes A; Mitry E; Dujon A; Le Pimpec Barthes F; Médioni J; Rougier P
Ann Thorac Surg; 2010 Feb; 89(2):375-80. PubMed ID: 20103301
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors.
Guarneri V; Broglio K; Kau SW; Cristofanilli M; Buzdar AU; Valero V; Buchholz T; Meric F; Middleton L; Hortobagyi GN; Gonzalez-Angulo AM
J Clin Oncol; 2006 Mar; 24(7):1037-44. PubMed ID: 16505422
[TBL] [Abstract][Full Text] [Related]
27. Long-term survival after repeated resection of pulmonary metastases from colorectal cancer.
Welter S; Jacobs J; Krbek T; Krebs B; Stamatis G
Ann Thorac Surg; 2007 Jul; 84(1):203-10. PubMed ID: 17588413
[TBL] [Abstract][Full Text] [Related]
28. The significance of prognostic factors for the resection of pulmonary metastases of breast cancer.
Friedel G; Linder A; Toomes H
Thorac Cardiovasc Surg; 1994 Apr; 42(2):71-5. PubMed ID: 8016831
[TBL] [Abstract][Full Text] [Related]
29. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion].
Zhao WH; Xu BH; Zhang P; Li Q; Zhao LM; Sun Y
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):137-40. PubMed ID: 17645853
[TBL] [Abstract][Full Text] [Related]
30. Study of HER2/neu status in Qatari women with breast carcinoma.
Rasul KI; Mohammaed K; Abdalla AS; Chong-Lopez A; Ahmad MA; Al-Homsi MU; Al-Hassan AM; Al-Alosi AS; Bener A
Saudi Med J; 2003 Aug; 24(8):832-6. PubMed ID: 12939666
[TBL] [Abstract][Full Text] [Related]
31. Expression levels and clinical-pathological correlations of HER2/neu in primary and metastatic human breast cancer.
Stefano R; Agostara B; Calabrò M; Campisi I; Ravazzolo B; Traina A; Miele M; Castagnetta L
Ann N Y Acad Sci; 2004 Dec; 1028():463-72. PubMed ID: 15650272
[TBL] [Abstract][Full Text] [Related]
32. Histopathologic prognostic factors in resected colorectal lung metastases.
Shiono S; Ishii G; Nagai K; Yoshida J; Nishimura M; Murata Y; Tsuta K; Nishiwaki Y; Kodama T; Ochiai A
Ann Thorac Surg; 2005 Jan; 79(1):278-82; discussion 283. PubMed ID: 15620957
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary metastasectomy for pulmonary metastases of head and neck squamous cell carcinomas.
Shiono S; Kawamura M; Sato T; Okumura S; Nakajima J; Yoshino I; Ikeda N; Horio H; Akiyama H; Kobayashi K;
Ann Thorac Surg; 2009 Sep; 88(3):856-60. PubMed ID: 19699911
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors for recurrent breast cancer patients with an isolated, limited number of lung metastases and implications for pulmonary metastasectomy.
Yhim HY; Han SW; Oh DY; Han W; Im SA; Kim TY; Kim YT; Noh DY; Chie EK; Ha SW; Park IA; Bang YJ
Cancer; 2010 Jun; 116(12):2890-901. PubMed ID: 20564396
[TBL] [Abstract][Full Text] [Related]
35. Surgical management of pulmonary metastases from colorectal cancer in 153 patients.
Yedibela S; Klein P; Feuchter K; Hoffmann M; Meyer T; Papadopoulos T; Göhl J; Hohenberger W
Ann Surg Oncol; 2006 Nov; 13(11):1538-44. PubMed ID: 17009154
[TBL] [Abstract][Full Text] [Related]
36. Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma.
Inoue M; Ohta M; Iuchi K; Matsumura A; Ideguchi K; Yasumitsu T; Nakagawa K; Fukuhara K; Maeda H; Takeda S; Minami M; Ohno Y; Matsuda H;
Ann Thorac Surg; 2004 Jul; 78(1):238-44. PubMed ID: 15223436
[TBL] [Abstract][Full Text] [Related]
37. Pulmonary resections of single metastases from colorectal cancer.
Rotolo N; De Monte L; Imperatori A; Dominioni L
Surg Oncol; 2007 Dec; 16 Suppl 1():S141-4. PubMed ID: 18037287
[TBL] [Abstract][Full Text] [Related]
38. Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma.
Harting MT; Blakely ML; Jaffe N; Cox CS; Hayes-Jordan A; Benjamin RS; Raymond AK; Andrassy RJ; Lally KP
J Pediatr Surg; 2006 Jan; 41(1):194-9. PubMed ID: 16410132
[TBL] [Abstract][Full Text] [Related]
39. Lower level of MAPK expression is associated with anthracycline resistance and decreased survival in patients with hormone receptor negative breast cancer.
Derin D; Eralp Y; Ozluk Y; Yavuz E; Guney N; Saip P; Igci A; Ozmen V; Kücücük S; Aslay I; Aydiner A; Topuz E
Cancer Invest; 2008 Aug; 26(7):671-9. PubMed ID: 18608215
[TBL] [Abstract][Full Text] [Related]
40. Prolonged overall survival after pulmonary metastasectomy in patients with breast cancer.
Meimarakis G; Rüttinger D; Stemmler J; Crispin A; Weidenhagen R; Angele M; Fertmann J; Hatz RA; Winter H
Ann Thorac Surg; 2013 Apr; 95(4):1170-80. PubMed ID: 23391172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
